Abstract
Interleukin-8 (IL-8), is a potent activator of polymorphonuclear leukocyte (PMN) functions including chemotaxis, superoxide anion production, and enzyme release and it is also chemotactic for lymphocytes. Additionally, it has recently been shown that IL-8 stimulates the formation of 5-lipoxygenase (LO) products of arachidonic acid (AA) by human PMNs. The purpose of the present study was to determine whether IL-8 also might affect the formation of 15-LO products from AA. Purified PMNs in phosphate buffered saline were preincubated with and without exogenous AA (10−5–10−4 M) for 10 min. Then IL-8 was added in biologically relevant concentrations ranging from 0.1 to 100 ng/ml and incubation was carried out for 5 min at 37°C. Lipids were then extracted from supernatants, and eicosanoids were determined by quantitative RP-HPLC. Compared with unstimulated cells, IL-8 resulted in a dose dependent increase in both LTB4 and 15-HETE (up to 125% and 40% at 100 ng/ml, respectively). This increase in eicosanoid formation required the presence of exogenous AA. These results indicate that IL-8 is both a potent stimulator of 5-LO activity and of 15-LO activity. LTB4 can induce both inflammation and contribute to hyperproliferation in the skin. 15-HETE in contrast has the ability to inhibit the effects induced by LTB4. Because IL-8 is able to stimulate both LTB4 and 15-HETE formation, the effect of IL-8 as a putative regulator of inflammatory processes may be dependent on the relative stimulation of 5-LO and 15-LO.
Similar content being viewed by others
References
R. D. R. Camp, N. J. Fincham, F. M. Cunningham, M. W. Greaves, J. Morris and A. Chu,Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound. J. Immunol.137, 3469–3471 (1986).
P. M. Dowd, R. D. R. Camp and M. W. Greaves,In vivo effects of human recombinant interleukin 1 in normal human skin. J. Invest. Dermatol.88, 250 (1987).
J.-M. Schröder and E. Christophers,Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J. Invest. Dermatol.87, 53–58 (1986).
T. Ternowitz, P. Bjerring, P. H. Andersen, J.-M. Schröder and K. Kragballe,Methotrexate inhibits the human C5a induced skin response in psoriatic patients. J. Invest. Dermatol.89, 192–196 (1987).
H. J. Showell, R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswanikumar, B. Corcoran and E. L. Becker,The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J. Exp. Med.143, 1154–1169 (1976).
K. Fogh, T. Herlin and K. Kragballe,Eicosanoids in acute and chronic psoriatic lesions. Leukotriene B 4,but not 12-hydroxy-eicosatetraenoic acid is present in biologically active concentrations in acute guttate lesions. J. Invest. Dermatol.92, 837–841 (1989).
E. A. Duell, C. N. Ellis and J. J. Voorhees,Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin. J. Invest. Dermatol.91, 446–450 (1988).
A. I. Mallet and F. M. Cunningham,Structural identification of platelet activating factor in psoriatic scale. Biochem. Biophys. Res. Commun.126, 192–198 (1985).
R. D. R. Camp, R. R. Jones, S. Brain, P. Woollard and M. W. Greaves,Production of intraepidermal microabscesses by topical application of Leukotriene B 4. J. Invest. Dermatol.82, 202–204 (1984).
P. M. Dowd, A. K. Black, P. M. Woollard, R. D. R. Camp and M. W. Greaves,Cutaneous responses to 12-hydroxy-eicosatetraenoic acid (12-HETE). J. Invest. Dermatol.84, 537–541 (1985).
F. W. Bauer, P. C. M. van de Kerkhof and R. M. Maassen-De Grood,Epidermal hyperproliferation following the induction of microabscesses by leukotriene B 4. Br. J. Dermatol.114, 409–412 (1986).
J. Y. Vanderhoek, R. W. Bryant and J. M. Bailey,Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid. J. Biol. Chem.255, 10064–10066 (1980).
T. Ternowitz, K. Fogh and K. Kragballe,15-Hydroxy-eicosatetraenoic acid (15-HETE) specifically inhibits LTB 4-induced chemotaxis of human neutrophils. Skin Pharmacol.1, 93–99 (1988).
T. Ternowitz, P. H. Andersen, P. Bjerring, K. Fogh, J.-M. Schröder and K. Kragballe,15-Hydroxy-eicosatetraenoic acid specifically inhibits the LTB 4-induced skin response. Arch. Dermatol. Res.281, 401–405 (1989).
K. Fogh, H. Søgaard, T. Herlin and K. Kragballe,Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxy-eicosatetraenoic acid (15-HETE). J. Am. Acad. Dermatol.18, 279–285 (1988).
K. Fogh, E. S. Hansen, T. Herlin, V. Knudsen, T. B. Henriksen, H. Ewald, C. Bünger and K. Kragballe,15-Hydroxy-eicosatetraenoic acid (15-HETE) inhibits carragheenan-induced experimental arthritis and reduces synovial fluid Leukotriene B 4 (LTB4). Prostaglandins37, 213–228 (1989).
R. M. Clancy, C. A. Dahinden and T. E. Hugli,Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-Formyl-Met-Leu-Phe or complement component C5a is independent on phospholipase activation. Proc. Natl. Acad. Sci. U.S.A.80, 7200–7204 (1983).
L. M. Ingraham, T. D. Coates, J. M. Allen, C. P. Higgings, R. L. Baehner and L. A. Boxer,Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood59, 1259–1266 (1982).
E. Morita, J.-M. Schröder and E. Christophers,Production of 15-hydroxyeicosatetraenoic acid by purified human eosinophils and neutrophils. Scand. J. Immunol32, 497–502 (1990).
J. Turk, R. L. Maas, A. R. Brash, L. J. Roberts and J. A. Oates,Arachidonic acid 15-lipoxygenase products from human eosinophils. J. Biol. Chem.257, 7068–7076 (1982).
J. Y. Vanderhoek, S. L. Ekborg and J. M. Baily,Nonsteroidal anti-inflammatory drugs stimulate 15-lipoxygenase/leukotriene pathway in human polymorphonuclear leukocytes. J. Allergy. Clin. Immunol.74, 412–417 (1984).
K. Fogh, T. Herlin and K. Kragballe,In vitro inhibition of leukotriene B 4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxyeicosatetraenoic acid (15-HETE) by human neutrophils. Arch. Dermatol. Res.280, 430–436 (1988).
J. Y. Vanderhoek, H. T. Karmin and S. L. Ekborg,Endogenous hydroxyeicosatetraenoic acids stimulate the human polymorphonuclear leukocyte 15-lipoxygenase pathway. J. Biol. Chem.260, 14482–14487 (1985).
C. G. Larsen, A. O. Anderson, E. Appella, J. J. Oppenheim and K. Matsushima,The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science243, 1464–1466 (1989).
J.-M. Schröder,The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J. Exp. Med.170, 847–863 (1989).
T. Yoshimura, K. Matsushima, S. Tanaka, E. A. Robinson, E. Appella, J. J. Oppenheim and E. J. Leonard,Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. U.S.A.84, 9233–9237 (1987).
C. G. Larsen, A. O. Anderson, J. J. Oppenheim and K. Matshusima,Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology68, 31–36 (1989).
A. Sica, K. Matshusima, J. M. Wang, N. Polentarutti, E. Dejana, F. Colotta and A. Mantovani,IL-1 transcriptionally activates the monocyte-derived neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology69, 548–553 (1989).
U. Wirtmueller, M. Baggiolini, A. L. de Weck and C. A. Dahinden,Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMET-LEU-PHE or C5a. Biochem. Biophys. Res. Commun.176, 972–978 (1991).
P. Borgeat and B. Samuelsson,Metabolism of arachidonic acid in polymorphonuclear leukocytes. Effect of calcium ionophore A 23187. Proc. Natl. Acad. Sci. U.S.A.76, 2148–2152 (1979).
C. A. Rouzer and B. Samuelsson,Reversible, calciumdependent membrane association of human leukocyte 5-lipoxygenase. Proc. Natl. Acad. Sci. U.S.A.84, 7393–7397 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fogh, K., Larsen, C.G., Iversen, L. et al. Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophilsin vitro . Agents and Actions 35, 227–231 (1992). https://doi.org/10.1007/BF01997504
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01997504